GSA CAPITAL PARTNERS LLP

Position in CHRS — Coherus Oncology, Inc.

CIK 1362033 LONDON, X0

Position in CHRS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$531,097

-$9,119 QoQ

Shares Held

379,355

+18.7% QoQ

Ownership

0.246%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#25

of 145 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. CHRS ranks #71 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$531,097	379,355	+18.7%	Shares	Sole	2026-08-06
2026-03-31	$540,216	319,655	-33.1%	Shares	Sole	2026-05-08
2025-12-31	$678,023	477,481	+4602.9%	Shares	Sole	2026-02-06
2025-03-31	$8,193	10,153	-91.7%	Shares	Sole	2025-05-08
2024-12-31	$169,770	123,022	+413.7%	Shares	Sole	2025-02-07
2023-12-31	$79,753	23,950	-75.2%	Shares	Sole	2024-02-16
2023-09-30	$361,482	96,653	-20.4%	Shares	Sole	2023-11-15
2023-06-30	$518,288	121,379	+84.8%	Shares	Sole	2023-08-14
2023-03-31	$449,230	65,677	-14.7%	Shares	Sole	2023-05-12
2022-12-31	$610,148	77,039	+333.3%	Shares	Sole	2023-02-13
2021-12-31	$283,784	17,781	+42.8%	Shares	Sole	2022-02-14
2021-06-30	$172,224	12,453	—	Shares	Sole	2021-08-05
No filing history on record for this holder in this stock.